BeyondSpring, Inc. (BYSI)
0.5847
+0.01
(+1.02%)
USD |
NASDAQ |
Nov 17, 16:00
0.5847
0.00 (0.00%)
After-Hours: 20:00
BeyondSpring Enterprise Value : 23.47M for Nov. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 23.47M |
| November 13, 2026 | 24.39M |
| November 12, 2026 | 24.39M |
| November 11, 2026 | 26.16M |
| November 10, 2026 | 23.50M |
| November 09, 2026 | 25.05M |
| November 06, 2026 | 25.42M |
| November 05, 2026 | 25.69M |
| November 04, 2026 | 27.62M |
| November 03, 2026 | 25.21M |
| November 02, 2026 | 32.87M |
| October 30, 2026 | 26.16M |
| October 29, 2026 | 20.90M |
| October 28, 2026 | 21.22M |
| October 27, 2026 | 18.63M |
| October 26, 2026 | 18.55M |
| October 23, 2026 | 17.35M |
| October 22, 2026 | 17.93M |
| October 21, 2026 | 20.03M |
| October 20, 2026 | 21.14M |
| October 19, 2026 | 20.74M |
| October 16, 2026 | 22.66M |
| October 15, 2026 | 23.60M |
| October 14, 2026 | 23.81M |
| October 13, 2026 | 24.62M |
| Date | Value |
|---|---|
| October 12, 2026 | 24.99M |
| October 09, 2026 | 24.58M |
| October 08, 2026 | 24.72M |
| October 07, 2026 | 26.19M |
| October 06, 2026 | 28.17M |
| October 05, 2026 | 32.05M |
| October 02, 2026 | 32.10M |
| October 01, 2026 | 33.19M |
| September 30, 2026 | 31.38M |
| September 29, 2026 | 24.98M |
| September 28, 2026 | 39.24M |
| September 25, 2026 | 25.14M |
| September 24, 2026 | 22.99M |
| September 23, 2026 | 23.06M |
| September 22, 2026 | 23.62M |
| September 21, 2026 | 23.61M |
| September 18, 2026 | 24.01M |
| September 17, 2026 | 22.33M |
| September 16, 2026 | 22.33M |
| September 15, 2026 | 24.04M |
| September 14, 2026 | 24.43M |
| September 11, 2026 | 24.60M |
| September 10, 2026 | 24.71M |
| September 09, 2026 | 19.04M |
| September 08, 2026 | 18.69M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.321B |
| Alnylam Pharmaceuticals, Inc. | 20.79B |
| Anika Therapeutics, Inc. | 154.24M |
| Savara, Inc. | 818.43M |
| Arrowhead Pharmaceuticals, Inc. | 6.454B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.064M |
| Total Expenses (Quarterly) | 2.064M |
| EPS Diluted (Quarterly) | -0.0701 |
| Earnings Yield | -33.49% |
| Normalized Earnings Yield | -33.49 |